Medication

September 25, 2019 - 1:16 pm
OxyContin maker Purdue Pharma's tentative legal settlement over the toll of the nation's opioid crisis is unlikely to reverse the consequences of the epidemic in the hardest-hit towns and regions, according to a report released Wednesday. Purdue reached a tentative deal this month to resolve the...
Read More
FILE - In this Oct. 2, 2016 file photo, Mac Miller performs at the 2016 The Meadows Music and Arts Festivals at Citi Field in Flushing, New York. Authorities say an Arizona man has become the second person arrested on drug charges in the investigation of the overdose death of the rapper. Havasu City, Ariz., police said Tuesday, Sept. 24, 2019, that Ryan Reavis has been charged with possession of marijuana and prescription drugs. (Photo by Scott Roth/Invision/AP, File)
September 25, 2019 - 10:52 am
HAVASU CITY, Arizona (AP) — Authorities say an Arizona man has become the second person arrested on drug charges in the investigation of the overdose death of rapper Mac Miller. Havasu City police said Tuesday that 36-year-old Ryan Reavis has been charged with possession of marijuana and...
Read More
FILE - In this Jan. 17, 2019, file photo, a sign with the Sackler name is displayed at the Metropolitan Museum of Art in New York. Their name used to be on a wing at the Louvre. But now the Sackler family wealth has become linked to sales of OxyContin, and their company, drug maker Purdue Pharma, is attempting to settle lawsuits over the opioid crisis. (AP Photo/Seth Wenig, File)
September 19, 2019 - 2:24 pm
For a family with its name on a wing of one of the world's most famous museums and a school at a prestigious university, members of the Sackler clan have done a remarkable job of vanishing from public life. The family owns OxyContin maker Purdue Pharma, which filed for bankruptcy this week as part...
Read More
September 19, 2019 - 8:20 am
The U.S. government will spend $3 million to find out if marijuana can relieve pain, but none of the money will be used to study the part of the plant that gets people high. Nine research grants announced Thursday are for work on CBD, the trendy ingredient showing up in cosmetics and foods, and...
Read More
On this Sept. 12, 2019, photo, House Speaker Nancy Pelosi, D-Calif., speaks at the Capitol in Washington. The good news is that it doesn’t look like a bitterly polarized Washington will stumble into another government shutdown. But as Democrats controlling the House unveil a stopgap, government-wide spending bill to keep the lights on and pay the troops, there’s scant evidence that power sharing in the U.S. Capitol will produce further legislative accomplishments anytime soon. (AP Photo/J. Scott Applewhite)
September 19, 2019 - 7:50 am
WASHINGTON (AP) — Putting her stamp on the health care issue that worries consumers the most, House Speaker Nancy Pelosi on Thursday unveiled an ambitious plan to lower drug prices for seniors on Medicare and younger people with private insurance. Pelosi, D-Calif., would empower Medicare to...
Read More
FILE - In this Nov. 5, 2018 file photo, a drugstore employee reaches for medicine from shelf in downtown Tehran, Iran. A cheap, daily pill that combines four drugs has been tested for the first time in the United States to see if it works as well among low-income Americans as it has in other countries to treat conditions leading to heart attacks and strokes. The results published Wednesday, Sept. 18, 2019, suggest the combo pill can lower blood pressure and bad cholesterol. Experts say the study may draw U.S. interest to a strategy that has been seen as useful only in places with limited access to medical care. (AP Photo/Ebrahim Noroozi, File)
September 18, 2019 - 3:45 pm
A cheap, daily pill that combines four drugs has been tested for the first time in the United States to see if it works as well among low-income Americans as it has in other countries to treat conditions leading to heart attacks and strokes. Experts said the study may draw U.S. interest to a...
Read More
FILE - In this Thursday, Sept. 12, 2019 file photo, cars pass Purdue Pharma headquarters in Stamford, Conn. The allegations surrounding wealthy donors such as the Sackler family have raised questions for the museums they supported, including whether to keep the family's name on prominent galleries. The billionaire family is notorious for its ties to the drug company Purdue Pharma, which developed OxyContin, a painkiller that has been at the center of the opioid crisis. (AP Photo/Frank Franklin II, File)
September 17, 2019 - 10:13 pm
NEW YORK (AP) — Ask the CEO and president of the Metropolitan Museum of Art whether he's accepting money from the Sacklers, the billionaire dynasty notorious for its ties to the drug company Purdue Pharma, and the answer is somewhat complicated. For one thing, it depends on which Sackler. "There...
Read More
FILE - In this April 2, 2018, file photo, a pharmacist in San Francisco poses for photos holding a bottle of OxyContin. In court papers filed in New York on Sunday, Sept. 15, 2019, Purdue Pharma, the drug's manufacturer, flied for Chapter 11 bankruptcy protection. (AP Photo/Jeff Chiu, File)
September 15, 2019 - 11:10 pm
OxyContin maker Purdue Pharma and its owners expressed sympathy but not responsibility for the nation's opioid crisis as the company filed for bankruptcy protection late Sunday night, part of a move to settle some 2,600 lawsuits — most from state and local governments. "Like families across America...
Read More
FILE - In this April 2, 2018, file photo, a pharmacist in San Francisco poses for photos holding a bottle of OxyContin. In court papers filed in New York on Sunday, Sept. 15, 2019, Purdue Pharma, the drug's manufacturer, flied for Chapter 11 bankruptcy protection. (AP Photo/Jeff Chiu, File)
September 15, 2019 - 8:46 pm
Purdue Pharma, the company that made billions selling the prescription painkiller OxyContin, filed for bankruptcy in White Plains, New York, days after reaching a tentative settlement with many of the state and local governments suing it over the toll of opioids. The filing was anticipated before...
Read More
FILE - In this July 31, 2010 file photo, Morgan Parmet, 24, of Washington, holds a bag of peanuts that she bought at Nationals Park, as the Philadelphia Phillies play against the Washington Nationals, in Washington. Government health experts are urging approval of a novel treatment for children with life-threatening peanut allergies. The daily medication is designed to build up children’s tolerance to peanuts and reduce dangerous allergic reactions. The panel of advisers to the Food and Drug Administration voted overwhelmingly in favor of the treatment from Aimmune Therapeutics. (AP Photo/Jacquelyn Martin, File)
September 13, 2019 - 2:46 pm
WASHINGTON (AP) — Government experts on Friday backed an experimental treatment for children with peanut allergies that could become the first federally approved option for preventing life-threatening reactions. The treatment is daily capsules of peanut powder that gradually help children build up...
Read More

Pages